Attached files
| file | filename |
|---|---|
| 8-K - 8-K - CytomX Therapeutics, Inc. | ctmx-8k_20170712.htm |
EXHIBIT 16.1
July 17, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by CytomX Therapeutics, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of CytomX Therapeutics, Inc. dated July 12, 2017. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers LLP
San Jose, CA